Telehealth ADHD Prescriptions Investigation


Girard Sharp attorneys are investigating potential claims on behalf of patients who were prescribed ADHD medications, such as Adderall, through telehealth providers Done or Cerebral. Recent reports suggest that these companies may be in violation of the Controlled Substances Act.

If you were prescribed medication for ADHD through one of these telehealth providers, you may have a claim. Speak to an attorney about your experience by calling us toll-free at (866) 981-4800 or filling out the form below.

Speak to a Lawyer

More About This Investigation

Done and Cerebral are online mental-health companies that prescribe stimulants like Adderall for treatment of attention-deficit hyperactivity disorder (“ADHD”), particularly during the Covid-19 pandemic when patients have been unable to attend in-person physician visits. Stimulants for the treatment of ADHD are classified by the U.S. government as controlled substances in the same category as OxyContin.

According to recent reports, the U.S. Drug Enforcement Administration has opened an investigation into these companies’ practices for prescribing stimulants via telemedicine as potentially being in violation of the Controlled Substances Act.

If you were prescribed medication for ADHD through Done or Cerebral, speak to one of our attorneys about your experience. Call us toll-free at (866) 981-4800 or fill out the form above for a free and confidential consultation.

Our Commitment to Excellence

Girard Sharp has earned national Tier 1 rankings for Mass Tort and Class Action Litigation and has been named to the U.S. News – Best Lawyers “Best Law Firms” list each year since 2013. Read about some of our results.

We have successfully resolved mass tort and class cases against some of the nation’s largest companies, including Apple, LG, and Google. Read about some of our results.

For a free consultation about your potential claims, contact one of our consumer protection lawyers at (866) 981-4800 or fill out the form at the top of this page.

Main Menu